Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 6Unknown 4Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 3Nausea 2Multiple Myeloma 2Cachexia 2Anorexia 2Weight Loss 1Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Opioid-Related Disorders 1Nutrition Disorders 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Cancer 1

Interventions

Dexamethasone 3Palonosetron 2Olanzapine 2Electroacupuncture 2Thalidomide 1Taxes 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Nausea × Olanzapine × Clear all
NCT03118986 2025-10-08

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

The Hospital for Sick Children

Phase 2 Recruiting
200 enrolled

Nausea, Neoplasms, Vomiting

NCT06588413 2024-11-22

FONDO-LOW

Augusta University

Phase 3 Recruiting
172 enrolled
Plasma cell

Multiple Myeloma, Nausea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡